BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 17046211)

  • 1. Aetiology and resistance patterns of community-acquired pneumonia in León, Nicaragua.
    Matute AJ; Brouwer WP; Hak E; Delgado E; Alonso E; Hoepelman IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):423-7. PubMed ID: 17046211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China].
    Liu YN; Chen MJ; Zhao TM; Wang H; Wang R; Liu QF; Cai BQ; Cao B; Sun TY; Hu YJ; Xiu QY; Zhou X; Ding X; Yang L; Zhuo JS; Tang YC; Zhang KX; Liang DR; Lü XJ; Li SQ; Liu Y; Yu YS; Wei ZQ; Ying KJ; Zhao F; Chen P; Hou XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):3-8. PubMed ID: 16638292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumonia in children.
    Berti I; Faraguna D
    N Engl J Med; 2002 Jun; 346(24):1916; author reply 1916. PubMed ID: 12063383
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan.
    Ishida T; Maniwa K; Kagioka H; Hirabayashi M; Onaru K; Tomioka H; Hayashi M; Tomii K; Gohma I; Ito Y; Hirai T; Ito I; Mishima M
    Respirology; 2008 Mar; 13(2):240-6. PubMed ID: 18339022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiologies and treatment outcomes in patients hospitalized with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W; Lulitanond V; Tantiwong P; Saelee R; Pisprasert V
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):156-61. PubMed ID: 15906660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults.
    Hashemi SH; Soozanchi G; Jamal-Omidi S; Yousefi-Mashouf R; Mamani M; Seif-Rabiei MA
    Trop Doct; 2010 Apr; 40(2):89-91. PubMed ID: 20305102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand.
    Lochindarat S; Suwanjutha S; Prapphal N; Chantarojanasiri T; Bunnag T; Deerojanawong J; Kunakorn M; Srisan P
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):814-9. PubMed ID: 17609060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
    Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM
    Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of community-acquired pneumonia treated at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W; Tantiwong P
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):355-61. PubMed ID: 12236437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores.
    Strålin K; Olcén P; Törnqvist E; Holmberg H
    Scand J Infect Dis; 2010 Jul; 42(6-7):426-34. PubMed ID: 20141490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel.
    Shibli F; Chazan B; Nitzan O; Flatau E; Edelstein H; Blondheim O; Raz R; Colodner R
    Isr Med Assoc J; 2010 Aug; 12(8):477-82. PubMed ID: 21337816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens.
    Gutiérrez F; Masiá M; Mirete C; Soldán B; Rodríguez JC; Padilla S; Hernández I; Royo G; Martin-Hidalgo A
    J Infect; 2006 Sep; 53(3):166-74. PubMed ID: 16375972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiological agents of community-acquired pneumonia in adult patients in Turkey; a multicentric, cross-sectional study.
    Köksal I; Ozlü T; Bayraktar O; Yılmaz G; Bülbül Y; Oztuna F; Caylan R; Aydın K; Sucu N;
    Tuberk Toraks; 2010; 58(2):119-27. PubMed ID: 20865563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
    Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
    Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices.
    Bartlett JG
    Semin Respir Infect; 1997 Dec; 12(4):329-33. PubMed ID: 9436960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.